Foundation Medicine Gets New CEO

5/12/11

Cambridge, MA-based Foundation Medicine, the developer of genomic-based cancer diagnostics, said today it has named Michael Pellini as its new CEO. Pellini was previously the president of Clarient, a unit of GE Healthcare. He replaces Alexis Borisy, a partner at Third Rock Ventures who was Foundation’s original CEO. Borisy will remain on Foundation Medicine’s board as chairman.

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @

Next Post

Related Topics

Related Posts

    

Xconomy Events Across the Network

XSITE 2012: The Xconomy Summit on Innovation, Technology & Entrepreneurship

Boston · 6/14/12
8:30 am - 5:00 pm

More Xconomy Events

Xconomy’s Most Popular

  1. Biotech IPOs Start to Show Some Modest Signs of Life
  2. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. Announcing Xconomy’s Napa Summit: Keeping America Growing
  5. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.